SCHEMBL7186338

SCHEMBL7186338

Cc1ccc(OC(C)(C)C)c(C=CC(=O)c2ccc(N)cc2)c1OC(C)(C)C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.47
CA2 P00918 3/20 0.47
KRAS P01116 1/20 0.47
CTSL P07711 1/20 0.43
CTSB P07858 1/20 0.43
CYP1B1 Q16678 1/20 0.43
ABCG2 Q9UNQ0 4/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
NPC1 O15118 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41
NFKB1 P19838 1/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PTPN1 P18031 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7186334 1.00 CA1 (0.47) CA1CA2KRASCTSLCTSB
SCHEMBL7190943 0.89 CAPN1 (0.47) CTSLCTSBABCG2MEN1KMT2A
SCHEMBL7190940 0.89 CAPN1 (0.47) CTSLCTSBABCG2MEN1KMT2A
SCHEMBL7179083 0.86 CA1 (0.46) CA1CA2KRASCTSLCTSB
SCHEMBL7179087 0.86 CA1 (0.46) CA1CA2KRASCTSLCTSB
SCHEMBL7187824 0.85 ABCG2 (0.40) CA1CA2ABCG2MEN1KMT2A
SCHEMBL7178727 0.85 ABCG2 (0.40) CA1CA2KRASABCG2MEN1
SCHEMBL7178729 0.85 ABCG2 (0.40) CA1CA2KRASABCG2MEN1
SCHEMBL7187821 0.85 ABCG2 (0.40) CA1CA2ABCG2MEN1KMT2A
SCHEMBL7183873 0.83 ELANE (0.45) ABCG2LMNAMAPTSMN1; SMN2PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed